Literature DB >> 12707004

Protein glycosylation in disease: new insights into the congenital muscular dystrophies.

Enca Martin-Rendon1, Derek J Blake.   

Abstract

Glycosylation is the most frequent modification of proteins and is important for many ligand-receptor interactions. Recently, defects in protein glycosylation have been linked to several forms of congenital muscular dystrophy that are frequently associated with brain abnormalities. Muscle-eye-brain disease and Walker-Warburg syndrome are caused by mutations in enzymes involved in O-mannosylation, whereas Fukuyama congenital muscular dystrophy and congenital muscular dystrophy type 1C are caused by mutations in genes that encode putative glycosyltransferases. The common factor in these disorders is defective processing and maturation of a protein called alpha-dystroglycan. This is thought to disrupt the link between alpha-dystroglycan and components of the extracellular matrix, and result in muscle disease and, in many cases, a neuronal-migration disorder.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12707004     DOI: 10.1016/S0165-6147(03)00050-6

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  17 in total

1.  Probing the oligomeric state and interaction surfaces of Fukutin-I in dilauroylphosphatidylcholine bilayers.

Authors:  P Marius; Yuk Ming Leung; T J Piggot; S Khalid; P T F Williamson
Journal:  Eur Biophys J       Date:  2011-11-11       Impact factor: 1.733

Review 2.  Pharmacokinetic and pharmacodynamic considerations in the development of therapeutic proteins.

Authors:  Iftekhar Mahmood; Martin D Green
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

3.  Aptamers selected against the unglycosylated EGFRvIII ectodomain and delivered intracellularly reduce membrane-bound EGFRvIII and induce apoptosis.

Authors:  Yingmiao Liu; Chien-Tsun Kuan; Jing Mi; Xiuwu Zhang; Bryan M Clary; Darell D Bigner; Bruce A Sullenger
Journal:  Biol Chem       Date:  2009-02       Impact factor: 3.915

4.  SysPTM: a systematic resource for proteomic research on post-translational modifications.

Authors:  Hong Li; Xiaobin Xing; Guohui Ding; Qingrun Li; Chuan Wang; Lu Xie; Rong Zeng; Yixue Li
Journal:  Mol Cell Proteomics       Date:  2009-04-14       Impact factor: 5.911

5.  Software tools for glycan profiling.

Authors:  Chuan-Yih Yu; Anoop Mayampurath; Haixu Tang
Journal:  Methods Mol Biol       Date:  2013

Review 6.  RAGE: a novel target for drug intervention in diabetic vascular disease.

Authors:  Barry I Hudson; Ann Marie Schmidt
Journal:  Pharm Res       Date:  2004-07       Impact factor: 4.200

Review 7.  Natural-product sugar biosynthesis and enzymatic glycodiversification.

Authors:  Christopher J Thibodeaux; Charles E Melançon; Hung-wen Liu
Journal:  Angew Chem Int Ed Engl       Date:  2008       Impact factor: 15.336

8.  Expression and purification of the transmembrane domain of Fukutin-I for biophysical studies.

Authors:  P Marius; J N Wright; I S Findlow; P T F Williamson
Journal:  Protein Expr Purif       Date:  2010-02-01       Impact factor: 1.650

Review 9.  Pediatric neurodegenerative white matter processes: leukodystrophies and beyond.

Authors:  Jonathan A Phelan; Lisa H Lowe; Charles M Glasier
Journal:  Pediatr Radiol       Date:  2008-04-30

Review 10.  Muscular dystrophies due to defective glycosylation of dystroglycan.

Authors:  F Muntoni; M Brockington; C Godfrey; M Ackroyd; S Robb; A Manzur; M Kinali; E Mercuri; M Kaluarachchi; L Feng; C Jimenez-Mallebrera; E Clement; S Torelli; C A Sewry; S C Brown
Journal:  Acta Myol       Date:  2007-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.